BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilad Y, Gellerman G, Lonard DM, O'Malley BW. Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations. Cancers (Basel) 2021;13:669. [PMID: 33562300 DOI: 10.3390/cancers13040669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chan HYE, Chen ZS. Multifaceted investigation underlies diverse mechanisms contributing to the downregulation of Hedgehog pathway-associated genes INTU and IFT88 in lung adenocarcinoma and uterine corpus endometrial carcinoma. Aging (Albany NY) 2022;14. [PMID: 36084949 DOI: 10.18632/aging.204262] [Reference Citation Analysis]
2 Khursheed S, Siddique HR, Tabassum S, Arjmand F. Water soluble transition metal [Ni(II), Cu(II) and Zn(II)] complexes of N-phthaloylglycinate bis(1,2-diaminocyclohexane). DNA binding, pBR322 cleavage and cytotoxicity. Dalton Trans 2022. [PMID: 35852297 DOI: 10.1039/d2dt01312f] [Reference Citation Analysis]
3 Rana K, Kumar Pandey S, Chauhan S, Preet S. Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer. International Journal of Pharmaceutics 2022;620:121744. [DOI: 10.1016/j.ijpharm.2022.121744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Thankarajan E, Walunj D, Bazylevich A, Prasad C, Hesin A, Patsenker L, Gellerman G. A novel, dual action chimera comprising DNA methylating agent and near-IR xanthene-cyanine photosensitizer for combined anticancer therapy. Photodiagnosis Photodyn Ther 2022;:102722. [PMID: 35032703 DOI: 10.1016/j.pdpdt.2022.102722] [Reference Citation Analysis]
5 Lavareze L, Scarini JF, de Lima-souza RA, Emerick C, de Sá RS, Aquino IG, Fernandes PM, Gonçalves MT, Helms MN, Altemani A, Egal ESA, Mariano FV. Salivary gland cancer in the setting of tumor microenvironment: Translational routes for therapy. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Abdus Subhan M, Torchilin VP. Advances with antibody-drug conjugates in breast cancer treatment. Eur J Pharm Biopharm 2021:S0939-6411(21)00271-X. [PMID: 34748933 DOI: 10.1016/j.ejpb.2021.10.016] [Reference Citation Analysis]
7 Migliore R, D'Antona N, Sgarlata C, Consoli GML. Co-Loading of Temozolomide and Curcumin into a Calix[4]arene-Based Nanocontainer for Potential Combined Chemotherapy: Binding Features, Enhanced Drug Solubility and Stability in Aqueous Medium. Nanomaterials (Basel) 2021;11:2930. [PMID: 34835694 DOI: 10.3390/nano11112930] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Sánchez-Valledor LF, Habermann TM, Murrieta-Alvarez I, Córdova-Ramírez AC, Rivera-Álvarez M, León-Peña A, Cantero-Fortiz Y, Olivares-Gazca JC, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center. World J Clin Oncol 2021; 12(9): 800-807 [PMID: 34631443 DOI: 10.5306/wjco.v12.i9.800] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mashayekhi V, Mocellin O, Fens MHAM, Krijger GC, Brosens LAA, Oliveira S. Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma. Theranostics 2021;11:9022-37. [PMID: 34522225 DOI: 10.7150/thno.60350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Löscher W, Klein P. New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal? Pharmacol Ther 2021;:107934. [PMID: 34216705 DOI: 10.1016/j.pharmthera.2021.107934] [Cited by in F6Publishing: 5] [Reference Citation Analysis]